How GLP-1 Drugs Like Ozempic and Mounjaro Are Reshaping the Global Economy (and Your Portfolio)
📌 GLP-1 · Obesity drugs · Global economy The “Obesity Drug Revolution” and a New Global Economic Map Over three parts, we look at how GLP-1 obesity drugs (Ozempic, Wegovy, Mounjaro, Zepbound) are not only changing bodies, but reshaping healthcare costs, consumer spending, industry structure, and investment flows. Table of Contents Part 1. The “Obesity Drug Revolution” – Drugs that reshape bodies, and the economy Part 2. A “less-eating world” and the industries it disrupts Part 3. In a slimming world, where does the money flow? Part 1 📘 Part 1. The “Obesity Drug Revolution” – Drugs that reshape bodies, and the economy By the mid-2020s, one of the most frequently cited themes in global financial markets and Wall Street reports ...